Medicure Inc
Medicure Inc. (MPH) is a Canadian pharmaceutical company focused on the development and commercialization of innovative therapies for cardiovascular and metabolic diseases. The company operates primarily in the pharmaceutical sector, specializing in the formulation of prescription medications aimed at improving patient outcomes in chronic conditions. Its core products include the proprietary drug Aggrastat, used in acute coronary syndrome, and other pipeline candidates designed to address unmet medical needs in the cardiovascular space.